Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm, Residual × Folfox protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 54 Rectal Neoplasms 25 Colonic Neoplasms 24 Carcinoma, Hepatocellular 21 Neoplasm Metastasis 15 Stomach Neoplasms 10 Pancreatic Neoplasms 6 Cholangiocarcinoma 6 Adenocarcinoma Of Esophagus 5 Recurrence 4 Esophageal Neoplasms 4 Biliary Tract Neoplasms 4 Neoplasms 3 Liver Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Neoplastic Cells, Circulating 2 Gastrointestinal Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Adenocarcinoma 2 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma 1 Operable T2-3N+M0 Rectal Cancer (Stage III) 1 Oligometastatic Gastric Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neuropathy, Painful 1 Neuralgia 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1

Interventions

Cyclophosphamide 19 Cytarabine 13 fludarabine 12 blinatumomab 11 Azacitidine 9 venetoclax 8 fludarabine phosphate 8 Blood Specimen Collection 8 Methotrexate 7 Dexamethasone 7 Lenalidomide 6 Daunorubicin 6 Vincristine 5 Rituximab 5 Mercaptopurine 5 daratumumab 4 Whole-Body Irradiation 4 Melphalan 4 Etoposide 4 obinutuzumab 3 Liquid Biopsy 3 Idarubicin 3 Granulocyte Colony-Stimulating Factor 3 Doxorubicin 3 Chemotherapy, Adjuvant 3 Busulfan 3 Asparaginase 3 trastuzumab deruxtecan 2 thymoglobulin 2 pegaspargase 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05534087 2024-11-29

CLAUDIA

Seoul National University Hospital

Phase 3 Recruiting

Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡